ArticleBlood advances2023
Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes.
Eduard Schulz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleBlood advances2023
Eduard Schulz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.